Welcome to our dedicated page for Ribbon Acquisition SEC filings (Ticker: RIBBU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ribbon Acquisition Corp (NASDAQ: RIBBU) files a range of documents with the U.S. Securities and Exchange Commission as part of its operations as a blank check company and its proposed business combination with DRC Medicine. These filings include registration statements related to its initial public offering, periodic reports, and current reports on Form 8-K that disclose material events.
A notable filing is the Form 8-K dated June 30, 2025, in which Ribbon reports entering into a Business Combination Agreement with DRC Medicine Inc. (PubCo), DRC Medicine Ltd., and DRC Merger Inc. This 8-K outlines key elements of the proposed transaction, including a share exchange between DRC Medicine shareholders and PubCo, the domestication of Ribbon from the Cayman Islands to Delaware, and the subsequent merger of Ribbon with a merger subsidiary that will remain a wholly owned subsidiary of PubCo. The filing also describes the business of DRC Medicine as the design and manufacture of AI-powered allergy and infection diagnostic kits and protective face masks.
On this page, users can review Ribbon’s SEC filings such as Form 8-K for material transaction announcements, the IPO-related registration statement on Form S-1 referenced in company press releases, and future filings like the Form S-4 registration statement and proxy statement/prospectus that DRC Medicine intends to file in connection with the Business Combination. These documents provide details on the structure of the SPAC, the terms and conditions of the proposed merger, the listing of units, Class A ordinary shares, and rights on Nasdaq, and the emerging growth company status disclosed by Ribbon.
Stock Titan’s platform associates these filings with AI-powered summaries that help explain complex sections of documents such as 8-Ks and registration statements, highlighting transaction terms, closing conditions, and structural changes like domestication and mergers, so readers can more easily understand the regulatory record for RIBBU.
Ribbon Acquisition Corporation, a Cayman Islands-based blank check company, files its annual report describing progress toward completing its initial business combination.
The company completed an IPO of 5,000,000 units at $10.00 each and a private placement of 220,000 units at $10.00, placing $50,000,000 of net proceeds into a U.S. trust account for the benefit of public shareholders. On June 30, 2025, Ribbon entered into a Business Combination Agreement with DRC Medicine Inc., DRC Medicine Ltd. and DRC Merger Inc. and is now focused on closing this transaction rather than seeking other targets.
As of March 31, 2026, the company had 4,793,446 ordinary shares outstanding and remained a pre-revenue SPAC relying on offering proceeds and sponsor loans to fund operating costs. Shareholders are granted redemption rights in connection with the business combination or a potential liquidation if no deal is completed within the approved extension period.
Ribbon Acquisition Corp. deposited $125,000 into its trust account on March 17, 2026 for the benefit of its public shareholders. This payment funded a one-month extension of the deadline to complete the company’s initial business combination, as permitted under previously approved extension and trust amendments.
Ribbon Acquisition Corp. postponed its Extraordinary General Meeting of Shareholders to April 13, 2026 at 10:00 a.m. Eastern Time to allow more time to solicit proxies for the proposals described in its proxy materials. Shareholders of record as of February 18, 2026 remain entitled to vote.
Proxies already submitted will be used at the adjourned meeting unless revoked, so shareholders who have already voted are not required to take additional action.
Ribbon Acquisition Corp. reported that it intends to adjourn its Extraordinary General Meeting of Shareholders, which was originally scheduled for March 16, 2026. The company is postponing the meeting to allow more time to solicit shareholder proxies on the proposals described in its meeting notice and proxy statement.
The new date and time of the adjourned meeting will be announced once determined. Only shareholders of record as of the close of business on February 18, 2026 remain entitled to vote, and previously submitted proxies will continue to be valid unless properly revoked.
Ribbon Acquisition Corp. has adjourned its Extraordinary General Meeting of Shareholders. The meeting, initially set for March 12, 2026 at 10:00 a.m. Eastern Time, is rescheduled to March 16, 2026 at the same time to allow more time to solicit proxy votes on the meeting proposals.
Only shareholders of record at the close of business on February 18, 2026 remain entitled to vote. Proxies already submitted will be used at the adjourned meeting unless properly revoked, so shareholders who have already voted do not need to take further action.
Ribbon Acquisition Corp. entered into a new financing arrangement by issuing a promissory note for $600,000 to Ribbon Investment Company Ltd, a shareholder of its sponsor. The note bears no interest, may be prepaid at any time without penalty, and becomes due promptly after the company completes its initial business combination.
The lender has waived any claim to the cash held in Ribbon Acquisition Corp.’s IPO trust account, meaning repayment will come from other company funds rather than the protected trust established for the business combination.
Ribbon Acquisition Corp. is asking shareholders to approve an amendment to its Trust Agreement so each one‑month SPAC extension requires a deposit into the trust of the lesser of $50,000 or $0.033 per then‑outstanding public share, instead of the previously disclosed $125,000 per month from the sponsor.
As of February 20, 2026, the trust held about $37,385,608.09 for 3,563,133 public shares, implying an estimated redemption price of roughly $10.49 per share. Shareholders can redeem regardless of how they vote, and a separate proposal would allow adjournment if support for the trust amendment is initially insufficient. The board recommends voting in favor, noting a pending business combination with DRC Medicine Ltd. that may require additional time to close.
Ribbon Acquisition Corp. has extended the time it has to complete its initial business combination by making additional deposits into its trust account for public shareholders. An aggregate of $250,000 was deposited, with $125,000 added in January 2026 and another $125,000 in February 2026.
Each monthly deposit funded a one-month extension of the deadline to consummate a business combination and was made under an Extension Amendment and Trust Amendment previously approved by shareholders. These funds are held in the trust account for the benefit of public shareholders.
RiverNorth Capital Management, LLC reported a significant ownership position in Ribbon Acquisition Corp. common shares. As of December 31, 2025, RiverNorth beneficially owned 400,000 common shares, representing 7.66% of the class. The firm has sole power to vote and dispose of all 400,000 shares and no shared voting or dispositive power.
The filing notes that other persons have the right to receive the proceeds from the sale of these securities, consistent with RiverNorth’s role as an investment adviser. RiverNorth certifies that the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of Ribbon Acquisition Corp.
Mizuho Financial Group, Inc. filed an amended Schedule 13G reporting beneficial ownership of 12,398 common shares of Ribbon Acquisition Corp, representing 0.2% of the class as of the event date December 31, 2025.
Mizuho reports sole voting and sole dispositive power over all 12,398 shares, with no shared voting or dispositive power. The filing notes that Mizuho Financial Group, Inc., Mizuho Bank, Ltd. and Mizuho Americas LLC may be deemed indirect beneficial owners of equity securities directly held by their wholly owned subsidiary, Mizuho Securities USA LLC.
The group states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Ribbon Acquisition Corp, and that ownership is 5 percent or less of the outstanding class.